Becton Seeks New Trial, Nix Of $114M Antitrust Verdict

By Erica Teichert ( October 15, 2013, 2:44 PM EDT) -- Becton Dickinson & Co. urged a Texas federal judge Friday to nix a $113. 5 million damages verdict in favor of longtime patent litigation rival Retractable Technologies Inc. and send the syringe market monopolization case back to a jury for a new trial, claiming the company couldn't prove Becton Dickinson's alleged actions led to decreased competition. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Law firms and the legal profession are facing new uncertainties, shifting the stress levels, economic pressures, and overall contentment of lawyers in private practice, according to the 2025 Law360 Pulse Lawyer Satisfaction Survey.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!